ya, I'm just trying to provide info and create ent
Post# of 30028
this company isn't slightly undervalued. it's either massively undervalued or dead. to me it hasn't mattered if I buy at 2, 1, .5, .25 etc, I've done it all, but left plenty of powder as security for road back up. you never know when bottom is and while in hindsight 20x your return is better than 5x a return, they're both great returns. I have managed to 10x my holdings for the cost of my original investment. I will look to 10x it again hopefully.
for magna, buying at 75 cents on dollar is even sweeter if instead of selling at 100% you sell at 110%, so there's value on way up for them too.
I'm waiting to buy more on other side of good news too. I agree bleeding continues outside some good news. I just think if biotech takes off again, it improves our odds.
and at a burn of $500k. $1mill from Anavex purchasing just 1,000 lympro tests (and it would likely be much higher) would be gigantic in security and validation. Even if anavex is a scam, it may see lympro as a scam way to valiate a p3 trial.